Recent SEC filings and disclosures provide limited updates on business operations. The company was featured in a March 2026 National Geographic cover article, enhancing public visibility.

• Kraig Biocraft Laboratories, Inc. filed its annual report (Form 10-K) for the fiscal year ended December 31, 2025, on March 30, 2026, disclosing financial results and liquidity metrics [S1].
• The company reported a net loss of approximately $3.62 million for the fiscal year ended December 31, 2025 [S1].
• As of December 31, 2025, the company had cash and cash equivalents of approximately $1.79 million and current liabilities of approximately $10.45 million, resulting in a current ratio of 0.18 [S1].
• No revenue was reported for the quarter ended September 30, 2019, the latest revenue figure available in filings [S1].
• The company is not currently involved in any material legal or administrative proceedings [S1].
• Kraig Biocraft Laboratories, Inc. was featured in a cover article of the March 2026 issue of National Geographic, which is expected to be distributed nationally in the coming weeks [S1].

The company has gained some public visibility through a feature in National Geographic's March 2026 issue, which may support brand recognition or awareness. However, detailed information on business execution, revenue generation, or product development is not disclosed in recent filings, limiting clarity on growth potential.

The company reported no revenue in the latest available period and a net loss of approximately $3.62 million for the fiscal year ended December 31, 2025. Liquidity ratios indicate significant current liabilities relative to current assets, suggesting financial constraints. The absence of detailed risk disclosures in recent filings limits transparency on potential challenges. The company’s smaller reporting status results in less comprehensive public disclosures, increasing uncertainty about business viability and execution risks.

Due to limited publicly available information on Kraig Biocraft Laboratories, Inc.'s business model, products, or competitive positioning, it is not possible to assess any sustainable competitive advantages or moat characteristics at this time.

• Liquidity Risk: The company’s current liabilities significantly exceed its current assets as of December 31, 2025, with a current ratio of 0.18, indicating potential challenges in meeting short-term obligations.
• Operating Losses: Kraig Biocraft Laboratories, Inc. reported a net loss of approximately $3.62 million for the fiscal year ended December 31, 2025, reflecting ongoing operating expenses without corresponding revenue.
• Limited Disclosure: As a smaller reporting company, the firm provides limited risk factor disclosures in recent SEC filings, reducing transparency on business and operational risks.
• Revenue Uncertainty: No revenue has been reported in recent periods, with the latest revenue figure from 2019 showing zero, raising questions about business model viability and commercialization progress.

• Kraig Biocraft Laboratories, Inc. is a smaller reporting company as defined by SEC rules [S1][S2].
• The company filed a Form 10-K for the fiscal year ended December 31, 2025, on March 30, 2026 [S1].
• As of December 31, 2025, the company had cash and cash equivalents of approximately $1.79 million and current assets of approximately $1.87 million [S1].
• Current liabilities as of December 31, 2025, were approximately $10.45 million, resulting in a current ratio of 0.18 and a cash ratio of 0.17, indicating liquidity constraints [S1].
• The company reported a net loss of approximately $3.62 million for the fiscal year ended December 31, 2025 [S1].
• No revenue was reported for the quarter ended September 30, 2019, the latest revenue figure available in filings [S1].
• Earnings per share basic and diluted were reported as zero for the fiscal year ended December 31, 2025 [S1].
• The company is not currently involved in any material legal or administrative proceedings [S1].
• Risk factors are not detailed in the latest filings due to smaller reporting company status, but are referenced in prior filings and on the company website [S1][S2].
• Kraig Biocraft Laboratories, Inc. was featured in a cover article of the March 2026 issue of National Geographic, indicating some public visibility [S1].